Defining and Characterizing the Progression of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is a progressive disease in which the risks of myocardial infarction, stroke, microvascular events, and mortality are all strongly associated with hyperglycemia (1). The disease course is primarily characterized by a decline in �-cell function and worsening of insulin resistance. The process is manifested clinically by deteriorations in multiple parameters, including A1C, fasting plasma glucose (FPG), and postprandial glucose levels. In this review, we will evaluate our current understanding of the role played by deteriorating �-cell function and other abnormalities linked with the progression of type 2 diabetes. An improved understanding of these abnormalities may provide the scientific groundwork for novel therapies that may help achieve and maintain good glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, the essential oil extracted from CW, primarily comprising esters (58.3%) and ketones (33.5%), has also demonstrated notable free radical scavenging activity and antioxidant potential [49].”
From Research Progress in Coconut Water: A Review of Nutritional Composition, Biological Activities, and Novel Processing Technologies (2025) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Regardless of the treatment regime, longitudinal studies in humans have demonstrated that beta-cell function generally deteriorates over time.49,50”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Following the induction of insulin resistance, islet beta-cells can maintain normoglycaemia and metabolic homeostasis by increasing their secretion of insulin and/or by increasing their number.49,96,97”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“The gradual decline in islet beta-cell number and function results in insulin levels becoming too low to promote metabolic homeostasis and T2D results.49,91”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Obesity has been estimated to induce an ~50% increase in islet beta-cell volume due to increased neogenesis.49”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 501–574 of 574
Abdelhamid, Y. A., & Deane, A. M. (2019) · Lessons from the ICU · doi:10.1007/978-3-030-24250-3_10 · Cited by 1
Badin, J. K. (2019) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2028 · Cited by 1
Important considerations about the article pragmatic approach to the treatment of diabetes mellitus
Garza-Ovalle, O. J., & Ovalle-Berumen, J. F. (2019) · Medicina Universitaria · doi:10.24875/rmu.m19000035
Deed, G., Rasalam, R. R., Khoo, C. L., Dover, T., & Forgione, N. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00704-0
An Insight into the Changing Scenario of Gut Microbiome during Type 2 Diabetes
Mukhuty, A., Fouzder, C., Das, S., & Chattopadhyay, D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90697
Medications Used for Diabetes Mellitus
Ghazaleh, H. A., & Khan, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-32004-1_9
Glucotoxicité et lipotoxicité dans le diabète de type 2 : comment protéger la cellule β ?
Scheen, A. J. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.05.005
Vitamin D in insulin sensitivity and obesity: Fact or fiction?
Pramono, A. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200828ap · Cited by 2
Utilising the therapeutic potential of xenin and related molecules for diabetes and obesity
Craig, S. L. (2020) · Ulster University Research Portal (Ulster University)
Chaudhuri, S. R., Majumder, A., & Sanya, D. (2021) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2021.08.00215
Utilizing Temporal Information in The EHR for Developing a Novel Continuous Prediction Model
Hsieh, K. (2019) · Digital Commons-TMC (Texas Medical Center)
Jahng, W. (2020) · York University Digital Library (York University)
Estrategia de lucha contra "Ceratitis Capitata w." en cítricos
Olmos, R. V. M. (2002) · Vida rural
Dyadic Associations between Body Mass Index, Stress and Type 2 Diabetes Complications
Fardfini, K. (2021) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2021-14797
Su, M., Zhang, Z., Zhou, L. N., Huang, C., & Nice, E. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00136-5
To Evaluate the Effectiveness of Dpp4 Inhibitors in Relation to Blood Sugar and Lipid Profile
Sharma, M., Varma, A., Bhat, K., & Rakholia, R. (2022) · Indian Journal of Public Health Research & Development · doi:10.37506/ijphrd.v13i3.18192
Venugopal Reddy, M., Sahayaraj, C., Begum, S. H., Sharon Sonia, S., & Vijayabhaskara Reddy, Y. (2023) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20230393
Involvement of a serotonin/GLP-1 circuit in adolescent isolation-induced diabetesPreprint
Kolling, L. J., Khan, K. M., Balasubramanian, N., Guo, D., Rahmouni, K., & Marcinkiewcz, C. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.12.544498
Стан забезпечення вітаміном D в осіб з інсулінорезистентністю
Бобрик, М. И. (2023) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2023-2-23
The Kk/Ay Mouse is a Model of Obese Type 2 Diabetes with Compromised Skeletal PropertiesPreprint
Chowdhury, N. N., Surowiec, R. K., Kohler, R. K., Reul, O. N., Segvich, D. M., & Wallace, J. M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4628677 · Cited by 2
Adaptive Autonomic and Neuroplastic Control in Diabetic Neuropathy: A Narrative Review
Marsili, F., Potgieter, P., & Birkill, C. F. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998253213231031050044
Kurniawan, F., Subekti, I., Yunir, E., Harbuwono, D. S., Purnamasari, D., Tarigan, T. J. E., Wisnu, W., Tahapary, D. L., Wafa, S., Astrella, C., et al. (2023) · Current Research in Translational Medicine · doi:10.1016/j.retram.2023.103437
Viñoles, F. C., Avila, J. R., Santiago, D., Vilera, N., Réquiz, Z. A., & Camperos, P. (2023) · Diabetes actual · doi:10.61156/2023.1.1.001
Predictors of Glycemic Worsening in the Next Year in Adults With Screen-Detected Type 2 Diabetes
Aguirre, R. S., Hannon, T. S., Considine, R. V., Patel, Y. R., Kirkman, M. S., & Mather, K. J. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0083
Andersen, J. W., Høgh, A. L., Lindholt, J. S., Søgaard, R., Støvring, H., Yderstræde, K. B., Sandbæk, A., & Dahl, M. (2025) · Clinical Epidemiology · doi:10.2147/clep.s487825
Jang, H. N., Hong, E. S., Yang, Y., Lee, S. O., Jang, M., Mari, A., Kwak, S. H., Park, K. S., Jang, H. C., & Jung, H. S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0741
Ayoade, O. B., Shahrestani, S. A., & Ruan, C. (2025) · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering · doi:10.1007/978-3-031-97352-9_9
Glycation of Myoglobin: A positive feedback loop reinforcing insulin resistance
Stacey, N., Silva, Z., Boorany, N., Palos, J. O., Potgieter, C., & Pieterse, L. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111752
Life’s essential 8 and risk of progression to diabetes among young adults with prediabetes
Lovre, D., Zu, Y., Cheung, H. Y., & Yoshida, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-19472-y
Post-Inhibitory Rebound by δ-Cells Converts Inhibition into Excitation and Confers Islet PlasticityPreprint
Tamayo, A., Rodriguez, D. H., Pereira, E., Camacho-Becerra, S., Gonçalves, L. M., Bergreen, P.-O., Sokolov, M., Drigo, R. A. E., Alcazar, O., & Rodriguez‐Diaz, R. (2025) · SSRN Electronic Journal · doi:10.1101/2025.11.10.687745
Ekström, N. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Kibirige, D., Sekitoleko, I., Lumu, W., & Nyirenda, M. J. (2023) · Figshare · doi:10.6084/m9.figshare.24406760
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26094488
Nazu, N. A., Wikström, K., Lamidi, M.-L., Lindström, J., Tirkkonen, H., Rautiainen, P., & Laatikainen, T. (2022) · Figshare · doi:10.6084/m9.figshare.21532609
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26738268
Pan, D., Guo, J., Su, Z., Meng, W., Wang, J., Guo, J., & Gu, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2525210/v1
Lejawa, M., Goławski, M., Fronczek, M., Osadnik, T., Paneni, F., Ruscica, M., Pawlas, N., Lisik, M., & Banach, M. (2024) · Figshare · doi:10.6084/m9.figshare.26943534
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26738271
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.26094402
Szépkúti, S., Bandur, S., Kovács, G., Ferenci, T., Svébis, M. M., Turbucz, P., & Tabák, Á. G. (2022) · Figshare · doi:10.6084/m9.figshare.21117530
Lejawa, M., Goławski, M., Fronczek, M., Osadnik, T., Paneni, F., Ruscica, M., Pawlas, N., Lisik, M., & Banach, M. (2024) · Figshare · doi:10.6084/m9.figshare.26943531
Lejawa, M., Goławski, M., Fronczek, M., Osadnik, T., Paneni, F., Ruscica, M., Pawlas, N., Lisik, M., & Banach, M. (2024) · Figshare · doi:10.6084/m9.figshare.26943528
Insulin pumps and artificial pancreas
Markakis, K. P., & Vazeou, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00296-x
Duc, T. Q., Di, K. N., Dang, D. K., Quynh, V. T., & Huyen, N. T. H. (2026) · CyTA - Journal of Food · doi:10.1080/19476337.2026.2613503
Ghadzi, S. S., Karlsson, M. O., de Mello, V. D., Uusitupa, M., Kjellsson, M. C., & Finnish Diabetes Prevention Study Group (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.28.708712
Redondo‐Castillejo, R., Quevedo-Torremocha, C., de la Cruz, M. L., Hernández-Martín, M., Bocanegra, A., Macho‐González, A., Cofrades, S., Álvarez, M. D., Bastida, S., López‐Oliva, M. E., et al. (2026) · Foods · doi:10.3390/foods15050878
Wu, Y., Yu, X., Chen, N., Zhao, S., Shen, W., & Zheng, W. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108293
Awwad, A. (2018) · theses.fr (ABES) · doi:10.70675/27dcfcbezb2a9z4c48zb673zf60decded54f · Cited by 1
In Vitro and in Silico approach of continuous subcutaneous insulin infusion system reliability
Girardot, S. (2020) · theses.fr (ABES) · doi:10.70675/4f3118b9zebc2z40b9z9baczafa4dd39494c · Cited by 1
Martens, T. W., Asche, S. E., JaKa, M. M., Johnson, M. L., DUNNIGAN, S. M., Haven, A. L., Morris, C., Barnaby, D., Maciosek, M. V., Dinh, J. M., et al. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108357
Kong, C. Y. A., Amaravadi, S. K., Costa, J., Ferreira, A. D. S., Vigário, P. D. S., & Alaparthi, G. K. (2026) · F1000Research · doi:10.12688/f1000research.180073.1
Barasara, S., Chauhan, Y. V., Gada, J. V., Sanamandra, P., Rahate, S. S., Paranjape, J., & Bhagwat, N. M. (2026) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_994_25
Chiu, C.-T., Hu, Y., & Chang, C. (2026) · SAGE Open Medical Case Reports · doi:10.1177/2050313x261463142
Omar, M. F. S. A., Alawi, Y. M., Tayara, A. A., Sahwan, A., Mohandes, M., Almustafa, A. A., & Haider, K. H. (2026) · Journal of Clinical and Translational Research · doi:10.36922/jctr026150026
Pîrșcoveanu, D. F. V., Pluta, I. D., Dîrnu, R., Vlădulescu, C., Trașcă, D.-M., Văruț, R. M., Kamal, A. M., Stoica, M., Pura, G., Popa, R., et al. (2026) · Molecules · doi:10.3390/molecules31142415
De, S., Lamidi, M., Wikström, K., Kivinen, P. K., Lavikainen, P., Koivunen, S., Rautiainen, P., & Laatikainen, T. K. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.07.001
Gut microbiome and diabetes: Emerging perspectives in metabolic regulation
Kaur, N., Kaur, N., Verma, A., & Sharma, R. K. (2026) · Scripta Medica · doi:10.5937/scriptamed57-61236
Minden, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-20529-2_13
Asias-Dinh, B. D., Rosario, N., Garey, K. W., Hussein, A., Madi, M., & Gee, J. S. (2026) · Annals of Pharmacotherapy · doi:10.1177/10600280261470410
Colin, P. J., Manolis, E., & Koomen, J. V. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70468
New avenues in metabolic disease treatment: duodenal mucosal resurfacing and gene therapy
Dias, C., Patel, S., Gaglani, T., & Thosani, N. C. (2026) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2026.101482
Hawthorne, A., Kelly, K., Tigue, M., El‐Mekkoussi, H., Waite, E. L., Erhan, Y., Manduchi, E., Dashti, S., Rozzo, A., Roman, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.26.754731
González-González, M. A., Pedrosa-Naudín, M. A., Fernández‐Lázaro, D., Planelles, I. D., Alvarez, E., & Gutiérrez‐Abejón, E. (2026) · Pharmaceuticals · doi:10.3390/ph19101607
Mechanisms of Hepatic Insulin Resistance and Its Contribution to the Pathogenesis of Type 2 Diabetes
Onyango, A. N. (2026) · Comprehensive physiology · doi:10.1002/cph4.70285
Giorgino, F., Haluzík, M., Alvarez, A., Lauand, F., Assaad-Khalil, S. H., Thacker, H. P., Klupa, T., Deyneli, O., & Rosenstock, J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71436
Kurmi, P. H., Singh, M. K., Gupta, V., Siddegowda, C., Shukla, J., Gofne, S. K., Lomte, N., Shendkar, K., Gangwani, D., Kumar, S., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03791-1
Metadata
- Authors
- Fonseca, V. A.
- Affiliations
- Tulane University (US)
- Corresponding author
- Fonseca, Vivian A.
- ORCID
- Fonseca, Vivian A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S151-S156
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811457
- OpenAlex
- W2128050336
- Cited by
- 573
- References
- 40
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 50 · 2023: 51 · 2022: 41 · 2021: 51 · 2020: 54 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 43 · 2015: 37 · 2014: 23 · 2013: 17 · 2012: 7
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes progression, beta-cell function decline, insulin resistance, hyperglycemia, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, microvascular complications, cardiovascular risk
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Resistance, Obesity, Prediabetic State, Weight Gain, Disease Progression, Postprandial Period, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.